• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

验证数据展示

  • IHC staining of human skeletal muscle using 16819-1-AP

    IHC staining of human skeletal muscle using 16819-1-AP

    Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue slide using 16819-1-AP (Calsequestrin 1 antibody at dilution of 1:50 (under 10x lens).

  • IHC staining of human skeletal muscle using 16819-1-AP

    IHC staining of human skeletal muscle using 16819-1-AP

    Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue slide using 16819-1-AP (Calsequestrin 1 antibody at dilution of 1:50 (under 40x lens).

Calsequestrin 1 Polyclonal antibody

Calsequestrin 1 Polyclonal Antibody for IHC, ELISA
Cat No. 16819-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IHC, ELISA

别名

Calmitin, Calsequestrin 1, CASQ, CASQ1, PDIB1

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
规格: 

-/ -

点击咨询售前客服

点击咨询售后客服

产品信息

16819-1-AP targets Calsequestrin 1 in IHC, ELISA applications and shows reactivity with human samples.

经测试应用 IHC, ELISA Application Description
经测试反应性 human
免疫原 Calsequestrin 1 fusion protein Ag10362 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 calsequestrin 1 (fast-twitch, skeletal muscle)
别名 Calmitin, Calsequestrin 1, CASQ, CASQ1, PDIB1
计算分子量 390 aa, 45 kDa
GenBank蛋白编号BC022289
基因名称 Calsequestrin 1
Gene ID (NCBI) 844
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDP31415
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.